miércoles, 24 de junio de 2015

STATISTICAL BRIEF #458: Trends in Statin Therapy among Adults (Age ≥ 18), United States, 2000 to 2011

STATISTICAL BRIEF #458: Trends in Statin Therapy among Adults (Age ≥ 18), United States, 2000 to 2011

AHRQ Electronic Newsletter banner image



AHRQ Stats: Statin Use

The number of adults who reported using prescribed statins more than doubled in 10 years, from 17.6 million in 2000–2001 to 40.8 million in 2010–2011. (Source: Agency for Healthcare Research and Quality, Medical Expenditure Panel Survey Statistical Brief #458: Trends in Statin Therapy among Adults (Age ≥ 18), United States, 2000 to 2011.)
MEPS Home
Medical Expenditure Panel Survey

STATISTICAL BRIEF #458:
Trends in Statin Therapy among Adults (Age ≥ 18), United States, 2000 to 2011


November 2014
Eric M. Sarpong and Samuel H. Zuvekas

Highlights

  • The number of adults (age ≥ 18) who reported using prescribed statins increased from an average 17.6 million annually in 2000–2001 to 40.8 million in 2010–2011.
  • Between 2000–2001 and 2010–2011, the number of adults who reported using prescribed generic versions of statins increased from 0.1 to 26.5 million annually.
  • The number of statin prescriptions filled by adults (age ≥ 18) increased from an average 102.2 million annually in 2000–2001 to 237.9 million in 2010–2011.
  • Among adults (age ≥ 18), annual total expenditures (in constant 2011 dollars) for all statins rose, on average, from $11.5 billion in 2000–2001 to $21.6 billion in 2010–2011.
  • Between 2000–2001 and 2010–2011, per user average annual expenditures (in constant 2011 dollars) among adults (age ≥ 18) fell from $652 to $529 for all statins, and rose from $653 to $1,051 for prescribed branded statins.

No hay comentarios: